16
Jun
2027
National Exhibition and Convention Center
16 Jun 2027 - 18 Jun 2027
stand 12D122

Fujian South Pharmaceutical Co.,Ltd.

About Fujian South Pharmaceutical Co.,Ltd.

Fujian South Pharmaceutical Co Ltd (FSP) was established in 2001, located in Mingxi County, Fujian Province, China. Today, FSP has become an important cGMP manufacturer for oncology APIs in China. FSP cultivates 7,000 acres of Taxus Wallichiana (Taxus yunnanensis), and it is the largest commercial utilizing in China. FSP is the main supplier for natural Paclitaxel, semi-synthesis Paclitaxel, Docetaxel, 10-DAB III (Taxus Baccata and Taxus Wallichiana) in the world. FSP is a main supplier for Gemcitabine, Irinotecan and the patented technologies for Docetaxel, Imatinib, and Erloitnib, etc. FSP is strong in R&D, with a pathbreaking team in Shanghai R&D Center. We hold 6 PCT patents and 33

...

Meet us at

  • CPHI & PMEC China 2027

    National Exhibition and Convention Center
    16 Jun 2027 - 18 Jun 2027
    stand 12D122
  • Country/Region:
    China
  • On CPHI since:
    2015
Company types
Manufacturer/Innovator
Contact info

Products from Fujian South Pharmaceutical Co.,Ltd. (1)

  • 5-aminolevulinic acid HCl

    Product 5-aminolevulinic acid HCl

    5-ALA HCl: 5-Aminolevulinic acid hydrochloride; 5-ALA methyl ester: 5-Aminolevulinic acid methyl ester hydrochloride.